Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
C608304-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $320.90 | |
C608304-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $880.90 |
Synonyms | Camlipixant|BLU-5937|TB7D2H7MZZ|UNII-TB7D2H7MZZ|1621164-74-6|4-Morpholinecarboxylic acid, 2-((2-(2,6-difluoro-4-((methylamino)carbonyl)phenyl)-7-methylimidazo(1,2-a)pyridin-3-yl)methyl)-, methyl ester, (2S)-|(S)-methyl-2-((2-(2,6-difluoro-4-(methylcarbamo |
---|---|
Grade | Moligand™ |
Action Type | ANTAGONIST |
Mechanism of action | P2X purinoceptor 3 antagonist |
ALogP | 3.2 |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | methyl (2S)-2-[[2-[2,6-difluoro-4-(methylcarbamoyl)phenyl]-7-methylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine-4-carboxylate |
---|---|
INCHI | InChI=1S/C23H24F2N4O4/c1-13-4-5-29-18(11-15-12-28(6-7-33-15)23(31)32-3)21(27-19(29)8-13)20-16(24)9-14(10-17(20)25)22(30)26-2/h4-5,8-10,15H,6-7,11-12H2,1-3H3,(H,26,30)/t15-/m0/s1 |
InChi Key | SEHLMRJSQFAPCJ-HNNXBMFYSA-N |
Canonical SMILES | CC1=CC2=NC(=C(N2C=C1)C[C@H]3CN(CCO3)C(=O)OC)C4=C(C=C(C=C4F)C(=O)NC)F |
Isomeric SMILES | CC1=CC2=NC(=C(N2C=C1)C[C@H]3CN(CCO3)C(=O)OC)C4=C(C=C(C=C4F)C(=O)NC)F |
PubChem CID | 76955630 |
Molecular Weight | 458.5 |
PubChem CID | 76955630 |
---|---|
ChEMBL Ligand | CHEMBL5095035 |
CAS Registry No. | 1621164-74-6 |
Enter Lot Number to search for COA:
1. Garceau D, Chauret N. (2019) BLU-5937: A selective P2X3 antagonist with potent anti-tussive effect and no taste alteration.. Pulm Pharmacol Ther, 56 (3): (56-62). [PMID:30902655] |